A: mixing a varying number of A172 eGFP/Luc tumor cells (500, 800, 1600, 3200, 6400, 8000, 16000, 32000, 48000 and 64000) with a varying number of stromal TNC-1 cells (100, 500, 1000, 2000, 4000, 56000, 810000, 210000, 200000, 30000 and 40000) respectively, initiate homogeneous spheroids.
should be corrected to
A: mixing a varying number of A172 eGFP/Luc tumor cells (500, 800, 1600, 3200, 6400, 8000, 16000, 32000, 48000 and 64000) with a varying number of stromal TNC-1 cells (100, 500, 1000, 2000, 4000, 8000, 10000, 20000, 30000 and 40000) respectively, initiate homogeneous spheroids.
B: 8000 A172 eGFP/Luc tumor cells were co-cultured with TNC-1 with an increasing cell numbers (0, 500, 1000, 2000, 4000, 6000, 8000, 10000, 200000, 30000 and 40000) demonstrated (...).
should be corrected to
B: 8000 A172 eGFP/Luc tumor cells were co-cultured with TNC-1 with an increasing cell numbers (0, 500, 1000, 2000, 4000, 6000, 8000, 10000, 20000, 30000 and 40000) demonstrated (...).
Figure legend, figure 4:
TNC-1 cells modulate sensitivity of TMZ to GBM tumor cells.
should be corrected to
TNC-1 cells modulate sensitivity of GBM tumor cells to TMZ.
Figure legend, figure 5:
TNC-1 cells modulate the sensitivity of Doxorubicin to GBM tumor cells.
should be corrected to
TNC-1 cells modulate the sensitivity of GBM tumor cells to Doxorubicin.
Corrections
6 November 2014
Please correct as follows
Figure legend, figure 2:
A: mixing a varying number of A172 eGFP/Luc tumor cells (500, 800, 1600, 3200, 6400, 8000, 16000, 32000, 48000 and 64000) with a varying number of stromal TNC-1 cells (100, 500, 1000, 2000, 4000, 56000, 810000, 210000, 200000, 30000 and 40000) respectively, initiate homogeneous spheroids.
should be corrected to
A: mixing a varying number of A172 eGFP/Luc tumor cells (500, 800, 1600, 3200, 6400, 8000, 16000, 32000, 48000 and 64000) with a varying number of stromal TNC-1 cells (100, 500, 1000, 2000, 4000, 8000, 10000, 20000, 30000 and 40000) respectively, initiate homogeneous spheroids.
B: 8000 A172 eGFP/Luc tumor cells were co-cultured with TNC-1 with an increasing cell numbers (0, 500, 1000, 2000, 4000, 6000, 8000, 10000, 200000, 30000 and 40000) demonstrated (...).
should be corrected to
B: 8000 A172 eGFP/Luc tumor cells were co-cultured with TNC-1 with an increasing cell numbers (0, 500, 1000, 2000, 4000, 6000, 8000, 10000, 20000, 30000 and 40000) demonstrated (...).
Figure legend, figure 4:
TNC-1 cells modulate sensitivity of TMZ to GBM tumor cells.
should be corrected to
TNC-1 cells modulate sensitivity of GBM tumor cells to TMZ.
Figure legend, figure 5:
TNC-1 cells modulate the sensitivity of Doxorubicin to GBM tumor cells.
should be corrected to
TNC-1 cells modulate the sensitivity of GBM tumor cells to Doxorubicin.
Competing interests
None